NFKB1 and allergic rhinitis: The control of allergic rhinitis induced by ovalbumin in C57BL/6 female mice after oral treatment with 5 mg/Kg alleviated nasal symptoms, inflammatory response, and oxidative stress, activating Nrf2/HO-1 and inactivating the NF-κB pathway through the reduction in Toll-like Receptor 4, NF-κB protein levels, and TNF-α and IL-5 production [89].